- Home
- ALDX vs FSTR Comparison
ALDX vs FSTR Comparison
Compare ALDX & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- FSTR
- Stock Information
- Founded
- ALDX 2004
- FSTR 1902
- Country
- ALDX United States
- FSTR United States
- Employees
- ALDX N/A
- FSTR N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- FSTR Metal Fabrications
- Sector
- ALDX Health Care
- FSTR Industrials
- Exchange
- ALDX Nasdaq
- FSTR Nasdaq
- Market Cap
- ALDX 313.4M
- FSTR 285.6M
- IPO Year
- ALDX 2014
- FSTR N/A
- Fundamental
- Price
- ALDX $5.26
- FSTR $26.18
- Analyst Decision
- ALDX Strong Buy
- FSTR Hold
- Analyst Count
- ALDX 2
- FSTR 1
- Target Price
- ALDX $9.50
- FSTR $25.00
- AVG Volume (30 Days)
- ALDX 647.5K
- FSTR 23.2K
- Earning Date
- ALDX 11-06-2025
- FSTR 11-06-2025
- Dividend Yield
- ALDX N/A
- FSTR N/A
- EPS Growth
- ALDX N/A
- FSTR 395.33
- EPS
- ALDX N/A
- FSTR 3.32
- Revenue
- ALDX N/A
- FSTR $506,999,000.00
- Revenue This Year
- ALDX N/A
- FSTR $3.93
- Revenue Next Year
- ALDX $36.23
- FSTR $4.51
- P/E Ratio
- ALDX N/A
- FSTR $7.89
- Revenue Growth
- ALDX N/A
- FSTR N/A
- 52 Week Low
- ALDX $1.14
- FSTR $17.16
- 52 Week High
- ALDX $7.20
- FSTR $29.78
- Technical
- Relative Strength Index (RSI)
- ALDX 48.59
- FSTR 48.61
- Support Level
- ALDX $5.13
- FSTR $25.94
- Resistance Level
- ALDX $5.79
- FSTR $27.52
- Average True Range (ATR)
- ALDX 0.28
- FSTR 0.72
- MACD
- ALDX -0.00
- FSTR -0.07
- Stochastic Oscillator
- ALDX 29.10
- FSTR 43.19
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.